Clinical Trials Directory

Trials / Completed

CompletedNCT02876614

Value of Radionuclide Cisternography

VALUE OF RADIONUCLIDE CISTERNOGRAPHY IN PATIENTS WITH CEREBROSPINAL FLUID LEAK

Status
Completed
Phase
Study type
Observational
Enrollment
113 (actual)
Sponsor
Hospices Civils de Lyon · Academic / Other
Sex
All
Age
Healthy volunteers
Not accepted

Summary

Radionuclide cisternography (RC) is a nuclear medicine examination based on intrathecal injection of \[111In\]diethylenetriaminepentaacetic acid (\[111In\]DTPA). It is prescribed for two recommendations: detection of cerebrospinal fluid (CSF) leak/fistula and diagnosis of normal pressure hydrocephalus. In the search part of CSF leak/fistula, RC offers the benefit of a 24-hour study of CSF unlike other reference tests. In addition to SPECT/CT imaging, the radiopharmacist performs sampling in nasal cavities and throat of the patient to collect a possible flow of CSF. These samples are analysed by radioactivity measurements and bring an added value to the exam. The interest of this examination for management of CSF leak/fistula remains unclear. The aim of this study is to identify and analyse results of all RC examinations performed since 2005 in the Nuclear Medicine department of the Neurological Hospital. The full analysis of patients will allow discussing the role of RC in management of CSF leak/fistulae in clinical practice.

Conditions

Timeline

Start date
2005-01-01
Primary completion
2005-12-01
Completion
2005-12-01
First posted
2016-08-24
Last updated
2016-08-24

Source: ClinicalTrials.gov record NCT02876614. Inclusion in this directory is not an endorsement.

Value of Radionuclide Cisternography (NCT02876614) · Clinical Trials Directory